• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于川芎茶调方散剂与丸剂生物药剂学性质探讨中成药“同方不同剂型”现象的科学合理性

Exploring the Scientific Rationality of the Phenomenon of "Different Dosage Forms of the Same Prescription" of Chinese Proprietary Medicine Based on Biopharmaceutical Properties of Powder and Pill of Chuanxiong Chatiao Prescription.

作者信息

Qu Zhong-Huan, Liu Lin, Zhang Xiao-Fei, Guo Dong-Yan, Zhai Bing-Tao, Zou Jun-Bo, Shi Ya-Jun

机构信息

Pharmacy College, Shaanxi University of Chinese Medicine, Xianyang, China.

Shangluo Hospital of Traditional Chinese Medicine, Shangluo, China.

出版信息

Front Pharmacol. 2022 Jun 9;13:893552. doi: 10.3389/fphar.2022.893552. eCollection 2022.

DOI:10.3389/fphar.2022.893552
PMID:35754501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9218571/
Abstract

The 2020 edition of the Pharmacopoeia of the People's Republic of China (Chinese Pharmacopoeia 2020 edition) has 255 Chinese prescriptions with different dosage forms, accounting for 21.09% of the total prescriptions (1,209) in Chinese Pharmacopoeia 2020 edition. However, the scientific rationality of the phenomenon of "Different Dosage Forms of the Same Prescription" of Chinese proprietary medicine has been less explored. Based on the dosage form theory of "components in pills release slowly and take effect in slow-acting manner, while in powders release quickly and take effect in fast-acting way," we provided the dissolution experiment and pharmacokinetics of Chuanxiong Chatiao powders and pills in order to rationalize the phenomenon of "Different Dosage Forms of the Same Prescription" of Chuanxiong Chatiao prescription. Chuanxiong Chatiao powders and pills were prepared in the laboratory referring to the preparation methods in the Chinese Pharmacopoeia 2020 edition, and the contents of tetramethylpyrazine, ferulic acid, nodakenin, and isoimperatorin were determined by the external standard method. We measured the dissolution of four analytes of Chuanxiong Chatiao powders and pills according to the second method for dissolution determination (paddle method) in the Chinese Pharmacopoeia 2020 edition, and their corresponding contents in each sampling point were determined by LC-MS/MS. We also provided a pharmacokinetic study of Chuanxiong Chatiao powders and pills. Six female domestic rabbits were divided into two groups (powder and pill groups) and given Chuanxiong Chatiao powders and pills (9.85 g/kg) by surgical administration separately. Blood samples were collected at 5, 15, 30, 45, 60, 90, 120, 150, 180, 240, 360, 480, 720, and 1,440 min after drug administration to measure the plasma concentration of the four analytes by LC-MS/MS. The results of dissolution experiment showed that the dissolution rate of four analytes in the powder group was greater than that of the pill group. However, the solubilities of tetramethylpyrazine and isoimperatorin were very low in the powder and pill, which may be related to their low solubility properties. The results of the pharmacokinetic study of Chuanxiong Chatiao powders and pills showed that (h) of ferulic acid and nodakenin in the powder group was 0.420 and 0.053 times that of the pill group and (h) of ferulic acid, nodakenin, and isoimperatorin of the powder group was 0.910, 0.262, and 0.661 times that of the pill group, respectively. The dissolution rate and pharmacokinetic parameters of four analytes in CXCTF could partly explain the scientific rationality of the classic theory of ", " as in Chinese, which is helpful for providing a basis for the comparison of subsequent dosage forms. The results of our studies also suggest the complexity of the design of dosage forms of Chinese proprietary medicines and imply that we should pay more attention to the scientific rationality of the phenomenon of "Different Dosage Forms of the Same Prescription."

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/9218571/9250de6042dc/fphar-13-893552-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/9218571/693540ccd216/fphar-13-893552-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/9218571/b3dffeec0caa/fphar-13-893552-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/9218571/028606d55a21/fphar-13-893552-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/9218571/9250de6042dc/fphar-13-893552-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/9218571/693540ccd216/fphar-13-893552-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/9218571/b3dffeec0caa/fphar-13-893552-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/9218571/028606d55a21/fphar-13-893552-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/9218571/9250de6042dc/fphar-13-893552-g004.jpg
摘要

《中华人民共和国药典》2020年版(《中国药典》2020年版)中有255种不同剂型的中药处方,占《中国药典》2020年版总处方数(1209种)的21.09%。然而,中成药“同方不同剂型”现象的科学合理性鲜有探讨。基于“丸剂成分释放缓慢、起效慢,散剂释放快、起效快”的剂型理论,我们进行了川芎茶调散和丸剂的溶出实验及药代动力学研究,以阐明川芎茶调方“同方不同剂型”现象的合理性。参照《中国药典》2020年版的制备方法在实验室制备川芎茶调散和丸剂,采用外标法测定川芎嗪、阿魏酸、川续断皂苷乙和异欧前胡素的含量。按照《中国药典》2020年版溶出度测定第二法(桨法)测定川芎茶调散和丸剂中4种分析物的溶出度,各取样点的相应含量采用液相色谱 - 串联质谱法测定。我们还进行了川芎茶调散和丸剂的药代动力学研究。将6只雌性家兔分为两组(散剂组和丸剂组),分别通过灌胃给予川芎茶调散和丸剂(9.85 g/kg)。给药后5、15、30、45、60、90、120、150、180、240、360、480、720和1440分钟采集血样,采用液相色谱 - 串联质谱法测定4种分析物的血浆浓度。溶出实验结果表明,散剂组4种分析物的溶出速率大于丸剂组。然而,川芎嗪和异欧前胡素在散剂和丸剂中的溶解度非常低,这可能与其低溶解性有关。川芎茶调散和丸剂的药代动力学研究结果表明,散剂组阿魏酸和川续断皂苷乙的t1/2分别为丸剂组的0.420倍和0.053倍,散剂组阿魏酸、川续断皂苷乙和异欧前胡素的AUC0 - t分别为丸剂组的0.910倍、0.262倍和0.661倍。川芎茶调方中4种分析物的溶出速率和药代动力学参数可部分解释中医“丸者缓也,散者速也”经典理论的科学合理性,有助于为后续剂型比较提供依据。我们的研究结果还提示了中成药剂型设计的复杂性,意味着我们应更加关注“同方不同剂型”现象的科学合理性。

相似文献

1
Exploring the Scientific Rationality of the Phenomenon of "Different Dosage Forms of the Same Prescription" of Chinese Proprietary Medicine Based on Biopharmaceutical Properties of Powder and Pill of Chuanxiong Chatiao Prescription.基于川芎茶调方散剂与丸剂生物药剂学性质探讨中成药“同方不同剂型”现象的科学合理性
Front Pharmacol. 2022 Jun 9;13:893552. doi: 10.3389/fphar.2022.893552. eCollection 2022.
2
[Quality value transmitting of volatile components in personalized preparations:a case study of Menthae Haplocalycis Herba].[个性化制剂中挥发性成分的质量传递:以薄荷为例]
Zhongguo Zhong Yao Za Zhi. 2021 Aug;46(15):3780-3788. doi: 10.19540/j.cnki.cjcmm.20210525.303.
3
[Application of membrane separation technology in extraction process of Chuanxiong Chatiao granules].
Zhongguo Zhong Yao Za Zhi. 2012 Apr;37(7):934-6.
4
[Manufacturing classification system for oral solid dosage forms of traditional Chinese medicines(Ⅰ): classification of processing routes].[中药口服固体制剂生产分类系统(Ⅰ):炮制路线分类]
Zhongguo Zhong Yao Za Zhi. 2023 Jun;48(12):3169-3179. doi: 10.19540/j.cnki.cjcmm.20221014.301.
5
[Analysis of Chinese patent medicine prescriptions for Qi stagnation and blood stasis syndrome].[气滞血瘀证中成药方剂分析]
Zhongguo Zhong Yao Za Zhi. 2017 Jan;42(1):187-191. doi: 10.19540/j.cnki.cjcmm.20161222.005.
6
[Clinical practice guideline for migraine with traditional Chinese medicine(draft version for comments)].[中医偏头痛临床实践指南(征求意见稿)]
Zhongguo Zhong Yao Za Zhi. 2020 Nov;45(21):5057-5067. doi: 10.19540/j.cnki.cjcmm.20200903.502.
7
Influence of Different Dosage Forms on Pharmacokinetics of 6 Alkaloids in Raw Aconiti Kusnezoffii Radix () and Chebulae Fructus- (-) Processed by UPLC-MS/MS.不同剂型对生川乌和制诃子中 6 种生物碱药代动力学的影响 - UPLC-MS/MS 法
Biomed Res Int. 2020 Sep 21;2020:1942849. doi: 10.1155/2020/1942849. eCollection 2020.
8
Pharmacokinetics, brain distribution, release and blood-brain barrier transport of Shunaoxin pills.舒心丸的药代动力学、脑内分布、释放及血脑屏障转运。
J Ethnopharmacol. 2014 Feb 12;151(3):1133-1140. doi: 10.1016/j.jep.2013.12.027. Epub 2013 Dec 27.
9
[Study on effect of different processing methods on chemical components of Chuanxiong Rhizoma].[不同炮制方法对川芎化学成分的影响研究]
Zhongguo Zhong Yao Za Zhi. 2021 Jan;46(2):374-379. doi: 10.19540/j.cnki.cjcmm.20201022.303.
10
Traditional Chinese Medicine "Pill", an Ancient Dosage Form with Surprising Modern Pharmaceutical Characteristics.中药“丸剂”,一种具有惊人现代药学特性的古老剂型。
Pharm Res. 2021 Feb;38(2):199-211. doi: 10.1007/s11095-021-03007-x. Epub 2021 Feb 18.

本文引用的文献

1
Transporters (OATs and OATPs) contribute to illustrate the mechanism of medicinal compatibility of ingredients with different properties in yuanhuzhitong prescription.转运体(有机阴离子转运体和有机阴离子转运多肽)有助于阐明元胡止痛方中不同药性成分的配伍机制。
Acta Pharm Sin B. 2020 Sep;10(9):1646-1657. doi: 10.1016/j.apsb.2020.05.012. Epub 2020 Jun 27.
2
Pharmacokinetic comparative study of tetramethylpyrazine and ferulic acid and their compatibility with different concentration of gastrodin and gastrodigenin on blood-stasis migraine model by blood-brain microdialysis method.采用血脑微透析法对川芎嗪和阿魏酸及其与不同浓度天麻素和天麻苷元配伍对血瘀性偏头痛模型的药代动力学比较研究。
J Pharm Biomed Anal. 2020 Jan 5;177:112885. doi: 10.1016/j.jpba.2019.112885. Epub 2019 Sep 21.
3
A Metabolism-Based Synergy for Total Coumarin Extract of Radix and Ligustrazine on Migraine Treatment in Rats.基于代谢的协同作用:复方当归与川芎嗪治疗偏头痛大鼠的总香豆素提取物。
Molecules. 2018 Apr 25;23(5):1004. doi: 10.3390/molecules23051004.
4
[Analysis on dosage form theory and current application situation of traditional Chinese medicine pill].[中药丸剂剂型理论及应用现状分析]
Zhongguo Zhong Yao Za Zhi. 2017 Jun;42(12):2408-2412. doi: 10.19540/j.cnki.cjcmm.20170416.001.
5
Quantitative Evaluation of the Mechanism Underlying the Biotransportation of the Active Ingredients in Puerariae lobatae Radix and Chuanxiong rhizoma.
Phytother Res. 2015 Sep;29(9):1396-1403. doi: 10.1002/ptr.5393. Epub 2015 Jun 15.
6
Mechanism-based inactivation of cytochrome P450 2B6 by isoimperatorin.异欧前胡素对细胞色素 P450 2B6 的基于机制的失活作用。
Chem Biol Interact. 2015 Jan 25;226:23-9. doi: 10.1016/j.cbi.2014.12.009. Epub 2014 Dec 11.
7
[Effect of different compatibility of tetramethylpyrazine on its pharmacokinetics in vivo].川芎嗪不同配伍对其体内药代动力学的影响
Zhongguo Zhong Yao Za Zhi. 2012 May;37(9):1311-4.
8
[Comparative study on pharmacokinetics of tetramethylpyrazine, ferulic acid and their compatibility].川芎嗪、阿魏酸及其配伍的药代动力学比较研究
Zhongguo Zhong Yao Za Zhi. 2010 Apr;35(7):900-3.
9
Biotransformation of nodakenin and simultaneous quantification of nodakenin and its aglycone in incubated system of human intestinal bacteria by HPLC method.高效液相色谱法研究诺达叶素在人肠道菌培养体系中的生物转化及诺达叶素及其苷元的同步定量分析
J Asian Nat Prod Res. 2009;11(4):371-9. doi: 10.1080/10286020902767716.